New PET tracer targets cancer cells for sharper tumor imaging
Diagnosis
Recruiting now
This study tests a new imaging agent called F18 FBPA, which is designed to light up cancer cells during a PET/CT scan. The agent targets a protein often found on solid tumors, potentially making tumors easier to see. Researchers want to find the best dose and timing for the scan,…
Phase: PHASE1, PHASE2 • Sponsor: Heron Neutron Medical Corp. • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC